176 related articles for article (PubMed ID: 19784796)
1. FDG-PET can distinguish inflamed from non-inflamed plaque in an animal model of atherosclerosis.
Davies JR; Izquierdo-Garcia D; Rudd JH; Figg N; Richards HK; Bird JL; Aigbirhio FI; Davenport AP; Weissberg PL; Fryer TD; Warburton EA
Int J Cardiovasc Imaging; 2010 Jan; 26(1):41-8. PubMed ID: 19784796
[TBL] [Abstract][Full Text] [Related]
2. Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner.
Millon A; Dickson SD; Klink A; Izquierdo-Garcia D; Bini J; Lancelot E; Ballet S; Robert P; Mateo de Castro J; Corot C; Fayad ZA
Atherosclerosis; 2013 Jun; 228(2):339-45. PubMed ID: 23582588
[TBL] [Abstract][Full Text] [Related]
3. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX
Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602
[TBL] [Abstract][Full Text] [Related]
4. Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [
Hellberg S; Sippola S; Liljenbäck H; Virta J; Silvola JMU; Ståhle M; Savisto N; Metso J; Jauhiainen M; Saukko P; Ylä-Herttuala S; Nuutila P; Knuuti J; Roivainen A; Saraste A
Atherosclerosis; 2017 Aug; 263():369-376. PubMed ID: 28457625
[TBL] [Abstract][Full Text] [Related]
5. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study.
Tawakol A; Fayad ZA; Mogg R; Alon A; Klimas MT; Dansky H; Subramanian SS; Abdelbaky A; Rudd JH; Farkouh ME; Nunes IO; Beals CR; Shankar SS
J Am Coll Cardiol; 2013 Sep; 62(10):909-17. PubMed ID: 23727083
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging.
Vucic E; Dickson SD; Calcagno C; Rudd JH; Moshier E; Hayashi K; Mounessa JS; Roytman M; Moon MJ; Lin J; Tsimikas S; Fisher EA; Nicolay K; Fuster V; Fayad ZA
JACC Cardiovasc Imaging; 2011 Oct; 4(10):1100-9. PubMed ID: 21999870
[TBL] [Abstract][Full Text] [Related]
7. 18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis.
Nahrendorf M; Keliher E; Panizzi P; Zhang H; Hembrador S; Figueiredo JL; Aikawa E; Kelly K; Libby P; Weissleder R
JACC Cardiovasc Imaging; 2009 Oct; 2(10):1213-22. PubMed ID: 19833312
[TBL] [Abstract][Full Text] [Related]
8. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology.
Hyafil F; Cornily JC; Rudd JH; Machac J; Feldman LJ; Fayad ZA
J Nucl Med; 2009 Jun; 50(6):959-65. PubMed ID: 19443582
[TBL] [Abstract][Full Text] [Related]
9. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
[TBL] [Abstract][Full Text] [Related]
10. Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin.
Vucic E; Calcagno C; Dickson SD; Rudd JH; Hayashi K; Bucerius J; Moshier E; Mounessa JS; Roytman M; Moon MJ; Lin J; Ramachandran S; Tanimoto T; Brown K; Kotsuma M; Tsimikas S; Fisher EA; Nicolay K; Fuster V; Fayad ZA
JACC Cardiovasc Imaging; 2012 Aug; 5(8):819-28. PubMed ID: 22897996
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography.
Tawakol A; Migrino RQ; Hoffmann U; Abbara S; Houser S; Gewirtz H; Muller JE; Brady TJ; Fischman AJ
J Nucl Cardiol; 2005; 12(3):294-301. PubMed ID: 15944534
[TBL] [Abstract][Full Text] [Related]
12. Combined PET/DCE-MRI in a Rabbit Model of Atherosclerosis: Integrated Quantification of Plaque Inflammation, Permeability, and Burden During Treatment With a Leukotriene A4 Hydrolase Inhibitor.
Calcagno C; Lairez O; Hawkins J; Kerr SW; Dugas MS; Simpson T; Epskamp J; Robson PM; Eldib M; Bander I; K-Raman P; Ramachandran S; Pruzan A; Kaufman A; Mani V; Ehlgen A; Niessen HG; Broadwater J; Fayad ZA
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):291-301. PubMed ID: 29413439
[TBL] [Abstract][Full Text] [Related]
13. Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis.
Ye YX; Calcagno C; Binderup T; Courties G; Keliher EJ; Wojtkiewicz GR; Iwamoto Y; Tang J; Pérez-Medina C; Mani V; Ishino S; Johnbeck CB; Knigge U; Fayad ZA; Libby P; Weissleder R; Tawakol A; Dubey S; Belanger AP; Di Carli MF; Swirski FK; Kjaer A; Mulder WJ; Nahrendorf M
Circ Res; 2015 Oct; 117(10):835-45. PubMed ID: 26394773
[TBL] [Abstract][Full Text] [Related]
14. [The value of (18)F-fluorodeoxyglucose positron emission tomography-computed tomography ((18)F-FDG PET-CT) in evaluating the stability of atherosclerotic plaques].
Zhang YH; Tian P; Xu JP; Wang ZZ; Zhao XZ; Nie MX; Zhang MD; Zhao QM; Zhao BT; Song SJ
Zhonghua Nei Ke Za Zhi; 2019 Nov; 58(11):808-813. PubMed ID: 31665855
[No Abstract] [Full Text] [Related]
15. The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial.
Emami H; Vucic E; Subramanian S; Abdelbaky A; Fayad ZA; Du S; Roth E; Ballantyne CM; Mohler ER; Farkouh ME; Kim J; Farmer M; Li L; Ehlgen A; Langenickel TH; Velasquez L; Hayes W; Tawakol A
Atherosclerosis; 2015 Jun; 240(2):490-6. PubMed ID: 25913664
[TBL] [Abstract][Full Text] [Related]
16. Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention.
Ishii H; Nishio M; Takahashi H; Aoyama T; Tanaka M; Toriyama T; Tamaki T; Yoshikawa D; Hayashi M; Amano T; Matsubara T; Murohara T
Clin Ther; 2010 Dec; 32(14):2337-47. PubMed ID: 21353104
[TBL] [Abstract][Full Text] [Related]
17. Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18F-FDG PET.
Calcagno C; Cornily JC; Hyafil F; Rudd JH; Briley-Saebo KC; Mani V; Goldschlager G; Machac J; Fuster V; Fayad ZA
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1311-7. PubMed ID: 18467641
[TBL] [Abstract][Full Text] [Related]
18. Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholine.
Hellberg S; Silvola JM; Kiugel M; Liljenbäck H; Metsälä O; Viljanen T; Metso J; Jauhiainen M; Saukko P; Nuutila P; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A
Cardiovasc Diabetol; 2016 Feb; 15():26. PubMed ID: 26852231
[TBL] [Abstract][Full Text] [Related]
19. Near-infrared fluorescence imaging of murine atherosclerosis using an oxidized low density lipoprotein-targeted fluorochrome.
Lu T; Wen S; Cui Y; Ju SH; Li KC; Teng GJ
Int J Cardiovasc Imaging; 2014 Jan; 30(1):221-31. PubMed ID: 24170262
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effect of statin is continuously working throughout use: a prospective three time point
Kang MK; Kim CJ; Choo EH; Han EJ; Hwang BH; Kim JJ; Kim SH; O JH; Chang K
Int J Cardiovasc Imaging; 2019 Sep; 35(9):1745-1753. PubMed ID: 31312997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
